{"id":235901,"date":"2025-04-22T16:23:08","date_gmt":"2025-04-22T16:23:08","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=235901"},"modified":"2025-04-22T16:23:08","modified_gmt":"2025-04-22T16:23:08","slug":"steaua-gigantului-european-novo-nordisk-apune-rivalul-american-eli-lilly-a-testat-cu-succes-un-nou-medicament-pentru-slabit-sub-forma-de-pastile","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=235901","title":{"rendered":"Steaua gigantului european Novo Nordisk apune: Rivalul american Eli Lilly a testat cu succes un nou medicament pentru sl\u0103bit sub form\u0103 de pastile"},"content":{"rendered":"<p>\nAc\u0163iunile Novo Nordisk au sc\u0103zut cu peste 10% la Copenhaga, dup\u0103 ce gigantul farmaceutic Eli Lilly a publicat rezultate promi\u0163\u0103toare ale unui studiu privind un tratament experimental \u00eempotriva obezit\u0103\u0163ii, scrie Investing.<\/p>\n<p>\nSc\u0103derea Novo Nordisk a avut loc \u00een timp ce Eli Lilly a crescut cu 10% pe bursa de la New York.<\/p>\n<p>\nCompeti\u0163ia pentru dezvoltarea unui tratament de sl\u0103bire se intensific\u0103 pe m\u0103sur\u0103 ce ambele companii \u00eencearc\u0103 s\u0103 domine noua pia\u0163\u0103. Rezultatele Eli Lilly pun presiune pe Novo Nordisk, ale c\u0103rei ac\u0163iuni sc\u0103zut deja cu aproximativ 30% de la \u00eenceputul anului.<\/p>\n<p>\nDe\u015fi injec\u0163iile pentru pierderea \u00een greutate produse de Novo Nordisk \u015fi Eli Lilly au adus miliarde de dolari \u00een noi venituri, companiile farmaceutice \u00eencearc\u0103 s\u0103 dezvolte tratamente care nu necesit\u0103 ace pentru a debloca poten\u0163ialul unei pie\u0163e estimate la 130 de miliarde de dolari p\u00e2n\u0103 la sf\u00e2r\u015fitul deceniului.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ac\u0163iunile Novo Nordisk au sc\u0103zut cu peste 10% la Copenhaga, dup\u0103 ce gigantul farmaceutic Eli Lilly a publicat rezultate promi\u0163\u0103toare ale unui studiu privind un tratament experimental \u00eempotriva obezit\u0103\u0163ii, scrie Investing. Sc\u0103derea Novo Nordisk a avut loc \u00een timp ce Eli Lilly a crescut cu 10% pe bursa de la New York. Competi\u0163ia pentru dezvoltarea [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[18365,32260,15494,26600],"class_list":["post-235901","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-eli-lilly","tag-medicament","tag-novo-nordisk","tag-slabit"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/235901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=235901"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/235901\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=235901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=235901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=235901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}